A study evaluating effect of macitentan on the vascular tone and regional blood flow non-invasively in healthy volunteers at high altitudes.

Trial Profile

A study evaluating effect of macitentan on the vascular tone and regional blood flow non-invasively in healthy volunteers at high altitudes.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Macitentan (Primary)
  • Indications Eisenmenger complex; Heart failure; Hypoxia; Portal hypertension; Pulmonary arterial hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Sep 2017 New trial record
    • 30 Aug 2017 Results presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top